(Q35544192)

8 August 2017

1 reference

title

Endocrine intervention for transsexuals (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

14 March 2024

author name string

Andy Levy

1

1 reference

8 August 2017

Anna Crown

2

1 reference

8 August 2017

Russell Reid

3

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14510900

14 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2265.2003.01821.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2265.2003.01821.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

14 March 2024

published in

Clinical Endocrinology

1 reference

8 August 2017

volume

59

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

409-418

1 reference

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

PROLACTIN LEVELS AND PITUITARY ENLARGEMENT IN HORMONE-TREATED MALE-TO-FEMALE TRANSSEXUALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Polycystic ovary syndrome and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Effects of early androgens on sex-typed activities and interests in adolescents with congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Gender reassignment and assisted reproduction: present and future reproductive options for transsexual people

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Gender differences in behaviour: activating effects of cross-sex hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Role of estrogen in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Relation between homocysteine and non-fatal stroke in peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

HIV among transgendered people

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Mortality and morbidity in transsexual subjects treated with cross-sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Attitudes toward transsexualism in a Swedish national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Health care problems of lesbian, gay, bisexual, and transgender patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Transsexualism or the gender dysphoria syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Gender change from female to male in classical congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

The effects of oestrogen exposure on bone mass in male to female transsexuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

"Being dealt with as a whole person." Care seeking and adherence: the benefits of culturally competent care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Epithelial ovarian cancer risk among women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Psychosexual development of women with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

Prospective study of exogenous hormones and risk of pulmonary embolism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01821.X

The effects of long-term androgen treatment on the ovary

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Mortality and morbidity in transsexual patients with cross-gender hormone treatment

14 March 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

The transsexual phenomenon

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Spontaneous rupture of a liver cell adenoma after long term Methyltestosterone: Report of a case successfully treated by emergency right hepatic lobectomy

14 March 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Gender reassignment and assisted reproduction: An ethical analysis. Bristol Centre for Reproductive Medicine Ethics Advisory Committee

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Challenges faced by homeless sexual minorities: comparison of gay, lesbian, bisexual, and transgender homeless adolescents with their heterosexual counterparts.

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Risk of venous thromboembolism in users of hormone replacement therapy

14 March 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

A follow-up study of 10 feminine boys

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Prenatal exposure to anticonvulsants and psychosexual development

14 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Long-term testosterone administration increases visceral fat in female to male transsexuals.

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

[Medical jurisprudence problems raised by transsexualism in 1986. Apropos of 148 cases of gender dysphoria]

14 March 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Breast cancer in a trans-sexual man receiving hormone replacement therapy

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females

14 March 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Effect of estrogens on prolactin secretion in transsexual subjects

14 March 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Follow-up of prolactin levels in long-term oestrogen-treated male-to-female transsexuals with regard to prolactinoma induction

14 March 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Estrogen-induced prolactinoma in a man.

14 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Transsexual healing: medicaid funding of sex reassignment surgery

14 March 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

14 March 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Metastatic prostatic carcinoma in a male-to-female transsexual

14 March 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Role of estrogen in the aetiology and treatment of mood disorders

14 March 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Oestradiol enhances testosterone-induced suppression of human spermatogenesis

14 March 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Abnormal sexual development and psychosexual issues.

14 March 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

The nosological position of transsexualism.

14 March 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

14 March 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Paraffinoma of the male breast: a case report

14 March 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

An epidemiological and demographic study of transsexuals in The Netherlands.

14 March 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Male-to-female transsexuals have female neuron numbers in a limbic nucleus

14 March 2024

52

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Factors predictive of regret in sex reassignment

14 March 2024

54

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Clinical characteristics of a total cohort of female and male applicants for sex reassignment: a descriptive study.

14 March 2024

55

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Psychiatric diagnosis of patients requesting sex reassignment surgery

14 March 2024

58

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Oral contraceptives and venous thromboembolism. A case-control study

14 March 2024

60

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Orgasm in the postoperative transsexual.

14 March 2024

61

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals

14 March 2024

62

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

The effect of androgen treatment on bone metabolism in female-to-male transsexuals

14 March 2024

63

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Enhancing transgender health care

14 March 2024

64

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Gender violence: transgender experiences with violence and discrimination

14 March 2024

65

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male

14 March 2024

66

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Physical and hormonal evaluation of transsexual patients during hormonal therapy

14 March 2024

68

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Physical and hormonal evaluation of transsexual patients: a longitudinal study

14 March 2024

69

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcome

14 March 2024

71

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

14 March 2024

Pituitary incidentalomas

72

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosteronetherapy: possible relationships of these changes to the development of peliosis hepatis and liver tumours

14 March 2024

75

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism

14 March 2024

78

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Transsexualism and osteoporosis.

14 March 2024

85

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Predictors and Prevention of Nonfatal Overdose Among Street-Recruited Injection Heroin Users in the San Francisco Bay Area, 1998–1999

14 March 2024

86

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals

14 March 2024

88

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Adolescents with gender identity disorder who were accepted or rejected for sex reassignment surgery: a prospective follow-up study.

14 March 2024

89

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks

14 March 2024

90

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

The Southeast Asian interpretation of gender dysphoria: an illustrative case report

14 March 2024

91

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Histopathology of the testes from male transsexuals on oestrogen therapy

14 March 2024

93

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group

14 March 2024

94

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Carcinoma of the prostate in a transsexual

14 March 2024

95

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Testicular atrophy after oestrogen therapy

14 March 2024

97

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Gender identity/role differentiation in adolescents affected by syndromes of abnormal sex differentiation

14 March 2024

98

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

Suction to the breasts of a transsexual male

14 March 2024

100

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01821.X

14 March 2024

Identifiers

1 reference

8 August 2017

1 reference